Benefits and risks of pharmacotherapy for irritable bowel syndrome (IBS): A decision analysis of alosetron use and its implications for clinical research

✍ Scribed by Ladabaum, Uri

• Book ID: 123525733
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 161 KB
• Volume: 124
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(03)81114-9